Kenya - engelsk - Pharmacy and Poisons Board

crown healthcare crownplex, mombasa road opp jkia flyover, p.o. - quinine dihydrochloride - solution for injection - quinine 600mg/2ml - other antimalarial antiprotozoals

Canada - engelsk - Health Canada

odan laboratories ltd - quinine sulfate - tablet - 300mg - quinine sulfate 300mg - antimalarials

Canada - engelsk - Health Canada

odan laboratories ltd - quinine sulfate - capsule - 200mg - quinine sulfate 200mg - antimalarials

Canada - engelsk - Health Canada

odan laboratories ltd - quinine sulfate - capsule - 300mg - quinine sulfate 300mg - antimalarials

Irland - engelsk - HPRA (Health Products Regulatory Authority)

actavis uk limited - quinine sulfate - coated tablets - 300 milligram - methanolquinolines

USA - engelsk - NLM (National Library of Medicine)

stat rx usa llc - quinine sulfate (unii: kf7z0e0q2b) (quinine - unii:a7v27phc7a) - quinine sulfate 324 mg - qualaquin (quinine sulfate) is an antimalarial drug indicated only for treatment of uncomplicated plasmodium falciparum malaria. quinine sulfate has been shown to be effective in geographical regions where resistance to chloroquine has been documented [see clinical studies (14) ]. qualaquin oral capsules are not approved for: - treatment of severe or complicated p. falciparum malaria. - prevention of malaria. - treatment or prevention of nocturnal leg cramps [see warnings and precautions (5.1) ]. qualaquin is contraindicated in patients with the following: - prolonged qt interval. one case of a fatal ventricular arrhythmia was reported in an elderly patient with a prolonged qt interval at baseline, who received quinine sulfate intravenously for p. falciparum malaria [see warnings and precautions (5.3) ]. - glucose-6-phosphate dehydrogenase (g6pd) deficiency. - hemolysis can occur in patients with g6pd deficiency receiving quinine. - known hypersensitivity reactions to quinine. these include, but are not li

USA - engelsk - NLM (National Library of Medicine)

ar scientific inc. - quinine sulfate (unii: kf7z0e0q2b) (quinine - unii:a7v27phc7a) - quinine sulfate 324 mg - qualaquin (quinine sulfate) is an antimalarial drug indicated only for treatment of uncomplicated plasmodium falciparum malaria. quinine sulfate has been shown to be effective in geographical regions where resistance to chloroquine has been documented [see clinical studies (14) ]. qualaquin oral capsules are not approved for: - treatment of severe or complicated p. falciparum malaria. - prevention of malaria. - treatment or prevention of nocturnal leg cramps [see warnings and precautions (5.1) ]. qualaquin is contraindicated in patients with the following: - prolonged qt interval. one case of a fatal ventricular arrhythmia was reported in an elderly patient with a prolonged qt interval at baseline, who received quinine sulfate intravenously for p. falciparum malaria [see warnings and precautions (5.3) ]. - glucose-6-phosphate dehydrogenase (g6pd) deficiency. - hemolysis can occur in patients with g6pd deficiency receiving quinine. - known hypersensitivity reactions to quinine. these include, but are

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - quinine sulfate - oral tablet - 300mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - quinine sulfate - oral tablet - 300mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - quinine bisulfate - oral tablet - 300mg